Guardant Health Inc’s recent filing unveils that its Director Hidalgo Medina Manuel unloaded Company’s shares for reported $0.12 million on Sep 12 ’25. In the deal valued at $54.16 per share,2,165 shares were sold. As a result of this transaction, Hidalgo Medina Manuel now holds 851 shares worth roughly $46626.29.
Then, Hidalgo Medina Manuel bought 2,165 shares, generating $117,251 in total proceeds.
Before that, Eltoukhy Helmy sold 300,000 shares. Guardant Health Inc shares valued at $17,835,995 were divested by the Co-Chief Executive Officer at a price of $59.45 per share. As a result of the transaction, Eltoukhy Helmy now holds 2,123,499 shares, worth roughly $116.35 million.
Mizuho initiated its Guardant Health Inc [GH] rating to an Outperform in a research note published on April 10, 2025; the price target was $55. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late January with a ‘”an Overweight”‘ rating. Guggenheim also remained covering GH and has increased its forecast on June 28, 2024 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of GH
On Monday, Guardant Health Inc [NASDAQ:GH] saw its stock fall -0.19% to $54.79. Over the last five days, the stock has lost -8.93%. Guardant Health Inc shares have risen nearly 120.31% since the year began. Nevertheless, the stocks have risen 79.35% over the past one year.
How much short interest is there in Guardant Health Inc?
A steep rise in short interest was recorded in Guardant Health Inc stocks on 2025-08-29, dropping by -1.37 million shares to a total of 8.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 9.4 million shares. There was a decline of -17.11%, which implies that there is a negative sentiment for the stock.
